Definitive Contract HHSD200201800011C
Award Date
12/12/17
Potential Completion Date
2/28/19
Potential Value
$23M
Federal Agency
CDC Pittsburgh
Awardee
Seqirus USA Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $44,980,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the production and delivery of influenza vaccines. The contract, which does not have a set-aside designation, covers the 2017 adult flu season with a completion date of February 28, 2018. Seqirus, through its Seqirus USA, Inc. division, is a major supplier of influenza vaccines to various federal government...
This is a $58,485,000.00 definitive, firm-fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) on December 23, 2016 to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The contract is for the delivery of pediatric influenza vaccines, with a period of performance ending on February 28, 2018. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal...
This is a Definitive Contract award from the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a foreign-owned for-profit organization, for the provision of influenza vaccines. The contract, valued at $309,633.70, is a Firm Fixed Price award without any set-aside designation. Seqirus USA Inc., through its Seqirus USA, Inc. division, will deliver influenza vaccines in various formulations to support annual flu vaccination programs for federal government populations,...
This is a firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The contract, valued at $303,100.00, is for the delivery of adult flu vaccines during the 2016-2017 flu season. The contract does not have a set-aside designation. Seqirus USA Inc. is the prime contractor and has been awarded multiple Indefinite Delivery Contracts (IDCs) by the CDC, Department of...
This federal contract award to Seqirus USA Inc. is for the delivery of flu vaccines. The $1,241,993.00 fixed-price purchase order was awarded on June 30, 2020 by the U.S. Department of Health and Human Services and has a completion date of July 30, 2020. Seqirus is a global biotechnology company that specializes in the manufacturing and delivery of influenza vaccines to various federal government agencies. The company has been awarded multiple Indefinite Delivery Contracts (IDCs) with agencies...
The U.S. Department of Health and Human Services has awarded a $22,428.00 firm-fixed-price purchase order contract to Seqirus USA Inc., a global biotechnology company, for the delivery of flu vaccines during the 2024-2025 season. This award is not a set-aside contract. Seqirus, through its Seqirus Usa, Inc. division, is a major supplier of influenza vaccines to various federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Health and Human...
This federal contract award was issued by the Department of Health and Human Services (HHS) to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $940,522.50 firm fixed price purchase order is for the delivery of flu vaccines. Seqirus USA Inc. has previously received awards from other federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Centers for Disease Control and...
This federal contract award is for the delivery of flu vaccines by Seqirus USA Inc., a global biotechnology company, to various U.S. government agencies including the Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, and Department of Justice. The contract, valued at $1,351,500.00, is a Firm Fixed Price Purchase Order with a completion date of July 7, 2019. The contract is not designated as a set-aside. Seqirus USA Inc. has been awarded numerous...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the provision of influenza virus vaccines. The contract, valued at $12,072,680.00, has an ultimate completion date of October 13, 2023. Seqirus USA Inc. is a global leader in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The company holds several...
The U.S. federal government has awarded a $141,185 delivery order contract to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract, with a performance period ending on August 30, 2024, is for the supply of influenza virus vaccines. Seqirus USA Inc. is the prime contractor and will be delivering the vaccines under this firm-fixed-price contract. This award is not associated with a set-aside program. Seqirus USA...